• Je něco špatně v tomto záznamu ?

Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis

V. Caisová, O. Uher, P. Nedbalová, I. Jochmanová, K. Kvardová, K. Masáková, G. Krejčová, L. Paďouková, J. Chmelař, J. Kopecký, J. Ženka,

. 2018 ; 59 (-) : 86-96. [pub] 20180407

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19000815

Immunotherapy emerges as a fundamental approach in cancer treatment. Up to date, the efficacy of numerous different immunotherapies has been evaluated. The use of microorganisms or their parts for immune cell activation, referred to as Pathogen-Associated Molecular Patterns (PAMPs), represents highly promising concept. The therapeutic effect of PAMPs can be further amplified by suitable combination of different types of PAMPs such as Toll like receptor (TLR) agonists and phagocytosis activating ligands. Previously, we used the combination of phagocytosis activating ligand (mannan) and mixture of TLR agonists (resiquimod (R-848), poly(I:C), inactivated Listeria monocytogenes) for successful treatment of melanoma in murine B16-F10 model. In the present study, we optimized the composition and timing of previously used mixture. Therapeutic mixture based on well-defined chemical compounds consisted of mannan anchoring to tumor cell surface by biocompatible anchor for membranes (BAM) and TLR agonists resiquimod, poly(I:C), and lipoteichoic acid (LTA). The optimization resulted in (1) eradication of advanced stage progressive melanoma in 83% of mice, (2) acquisition of resistance to tumor re-transplantation, and (3) potential anti-metastatic effect. After further investigation of mechanisms, underlying anti-tumor responses, we concluded that both innate and adaptive immunity are activated and involved in these processes. We tested the efficacy of our treatment in Panc02 murine model of aggressive pancreatic tumor as well. Simultaneous application of agonistic anti-CD40 antibody was necessary to achieve effective therapeutic response (80% recovery) in this model. Our results suggest that herein presented immunotherapeutic approach is a promising cancer treatment strategy with the ability to eradicate not only primary tumors but also metastases.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19000815
003      
CZ-PrNML
005      
20211209143518.0
007      
ta
008      
190107s2018 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.intimp.2018.03.038 $2 doi
035    __
$a (PubMed)29635103
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Caisová, Veronika $u Department of Medical Biology, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
245    10
$a Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis / $c V. Caisová, O. Uher, P. Nedbalová, I. Jochmanová, K. Kvardová, K. Masáková, G. Krejčová, L. Paďouková, J. Chmelař, J. Kopecký, J. Ženka,
520    9_
$a Immunotherapy emerges as a fundamental approach in cancer treatment. Up to date, the efficacy of numerous different immunotherapies has been evaluated. The use of microorganisms or their parts for immune cell activation, referred to as Pathogen-Associated Molecular Patterns (PAMPs), represents highly promising concept. The therapeutic effect of PAMPs can be further amplified by suitable combination of different types of PAMPs such as Toll like receptor (TLR) agonists and phagocytosis activating ligands. Previously, we used the combination of phagocytosis activating ligand (mannan) and mixture of TLR agonists (resiquimod (R-848), poly(I:C), inactivated Listeria monocytogenes) for successful treatment of melanoma in murine B16-F10 model. In the present study, we optimized the composition and timing of previously used mixture. Therapeutic mixture based on well-defined chemical compounds consisted of mannan anchoring to tumor cell surface by biocompatible anchor for membranes (BAM) and TLR agonists resiquimod, poly(I:C), and lipoteichoic acid (LTA). The optimization resulted in (1) eradication of advanced stage progressive melanoma in 83% of mice, (2) acquisition of resistance to tumor re-transplantation, and (3) potential anti-metastatic effect. After further investigation of mechanisms, underlying anti-tumor responses, we concluded that both innate and adaptive immunity are activated and involved in these processes. We tested the efficacy of our treatment in Panc02 murine model of aggressive pancreatic tumor as well. Simultaneous application of agonistic anti-CD40 antibody was necessary to achieve effective therapeutic response (80% recovery) in this model. Our results suggest that herein presented immunotherapeutic approach is a promising cancer treatment strategy with the ability to eradicate not only primary tumors but also metastases.
650    _2
$a adenokarcinom $x imunologie $x patologie $x terapie $7 D000230
650    _2
$a zvířata $7 D000818
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a imidazoly $x terapeutické užití $7 D007093
650    _2
$a imunoterapie $7 D007167
650    _2
$a lipopolysacharidy $x terapeutické užití $7 D008070
650    _2
$a tumor infiltrující lymfocyty $x imunologie $7 D016246
650    _2
$a mannany $x terapeutické užití $7 D008351
650    _2
$a melanom experimentální $x imunologie $x patologie $x terapie $7 D008546
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a neutrofily $x imunologie $7 D009504
650    _2
$a nádory slinivky břišní $x imunologie $x patologie $x terapie $7 D010190
650    12
$a fagocytóza $7 D010587
650    _2
$a poly I-C $x terapeutické užití $7 D011070
650    _2
$a kyseliny teichoové $x terapeutické užití $7 D013682
650    _2
$a toll-like receptory $x agonisté $7 D051193
650    _2
$a tumor burden $x účinky léků $7 D047368
655    _2
$a časopisecké články $7 D016428
700    1_
$a Uher, Ondřej $u Department of Medical Biology, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
700    1_
$a Nedbalová, Pavla $u Department of Medical Biology, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
700    1_
$a Jochmanová, Ivana $u 1st Department of Internal Medicine, Medical Faculty of P. J. Šafárik University in Košice, Košice, Slovakia. $7 xx0267304
700    1_
$a Kvardová, Karolína $u Department of Medical Biology, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
700    1_
$a Masáková, Kamila $u Department of Medical Biology, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
700    1_
$a Krejčová, Gabriela $u Department of Medical Biology, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
700    1_
$a Paďouková, Lucie $u Department of Medical Biology, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
700    1_
$a Chmelař, Jindřich $u Department of Medical Biology, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
700    1_
$a Kopecký, Jan $u Department of Medical Biology, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, v.v.i., České Budějovice, Czech Republic.
700    1_
$a Ženka, Jan $u Department of Medical Biology, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic. Electronic address: jzenka@gmail.com.
773    0_
$w MED00006034 $t International immunopharmacology $x 1878-1705 $g Roč. 59, č. - (2018), s. 86-96
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29635103 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20211209143517 $b ABA008
999    __
$a ok $b bmc $g 1364811 $s 1038938
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 59 $c - $d 86-96 $e 20180407 $i 1878-1705 $m International immunopharmacology $n Int Immunopharmacol $x MED00006034
LZP    __
$a Pubmed-20190107

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...